Asklepios secures early refinancing of schuldschein loan agreements via exchange and increase offer

• Successful extension of maturity profile through early refinancing of schuldschein maturities in 2022 and 2023
• Significant interest from existing investors

Hamburg, 8 November 2021. Asklepios Kliniken GmbH & Co. KGaA has achieved early refinancing for selected schuldschein loan agreements maturing in 2022 and 2023 in the context of an exchange and increase offer. The offer was addressed exclusively to existing investors, who had the opportunity to extend and increase their commitment by subscribing to a new schuldschein loan agreement.

The exchange and increase offer was made as part of Asklepios's active maturity management. Early refinancing of the schuldschein loan agreements from 2013, 2015 and 2017 enabled the volume-weighted average term of the maturity profile to be considerably extended. At the same time, the schuldschein loan agreement documentation was harmonised and updated further in the context of the refinancing.

"With the successful completion of the exchange offer, we managed to strengthen the Asklepios Group's financing situation and optimise it further in terms of a medium to long-term, balanced maturity profile,", says Hafid Rifi, Chief Financial Officer of the Asklepios Group. "The terms of the new schuldschein loan agreements of 5, 7 and 10 years are the perfect fit for our maturity profile. In addition, with 72% of the total volume of the new schuldschein loan agreement, we have achieved a high proportion of fixed-rate tranches and continued to take advantage of the currently beneficial interest rates."

Since 2010, Asklepios has been increasingly involving the capital market in its corporate financing, and it enjoys a good reputation among investors in Germany and abroad as a long-standing issuer. With the exchange and increase offer, Asklepios is again demonstrating its ability to successfully conclude complex schuldschein transactions.

"We are delighted with the outstanding response to the offer from our existing investors, which is partly reflected by an acceptance rate of 70% with regard to maturities next year," adds Benedikt Brörmann, Head of Corporate Finance & Treasury at Asklepios. "Overall, we managed to structure an offer that is attractive both to investors and to us as the issuer."

About Asklepios
Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has been developing dynamically since it was founded over 35 years ago. The Group currently has around 170 healthcare facilities throughout Germany. These include acute care hospitals of all different care levels, university hospitals, specialist clinics, psychiatric facilities, forensic institutions, rehabilitation clinics, nursing homes and medical centres. In the 2020 financial year, over 2.6 million patients were treated at the Asklepios Group's facilities. The company has more than 67,000 employees.

IR contact
Mirjam Constantin
Investor Relations/ Sustainability
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 - 61462 Königstein-Falkenstein
Tel.: +49 61 74 90-1166
Fax: +49 61 74 90-1110
ir@asklepios.com

PR contact
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 - 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
presse@asklepios.com

Visit Asklepios online, on Facebook or on YouTube:

www.asklepios.com

www.asklepios.com/ir

www.facebook.com/asklepioskliniken

www.youtube.com/asklepioskliniken

Nursing blog: "Wir sind Pflege"